Nonrulemaking
FDA
FDA-2024-E-0157
Patent Term Extension Application for BEYFORTUS® (nirsevimab-alip), Patent No. 11,661,449
8 docsNo comments
This is not an official government website.
© 2026 PLEJ LC. All rights reserved.
After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.
Showing 30 of 13,034 dockets
FDA-2024-E-0157
FDA-2026-H-2253
FDA-2024-E-0135
FDA-2024-E-0134
FAA-2026-2285
FAA-2002-11595
FAA-2026-3933
FAA-2026-3934
FAA-2026-3937
FDA-2026-E-1002
FDA-2026-H-0602
EERE-2026-FEMP-0067
FDA-2024-N-3533
DOT-OST-2026-1024
FAA-2025-4749
FAA-2023-1698
FAA-2025-0551
FAA-2026-1618
FAA-2026-3171
FAA-2026-3237
FDA-2026-H-1916
FAA-2026-3319
FAA-2026-3938